Monthly Archives: April 2014

Featured Stories
Retailers Accused of Selling Fraudulent Herbal Supplements

Major Retailers Accused of Selling Fraudulent Herbal Supplements

The NYS attorney general’s office has accused four national retailers of selling fraudulent dietary supplements.

Read More

Older Patients Face Heart Attack Risk Following Surgery

Older Hip Implant, Knee Replacement Patients Face Heart Attack Risk Following Surgery

An emerging report reveals that older hip implant and knee replacement patients face increased heart attack risks following surgery. The risk for acute myocardial infarction (AMI) was seen in the first two weeks after these surgical procedures.

Read More

Lawsuits over DePuy ASR Metal-on-Metal Hip Implants Continue to Mount

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be hit with lawsuits over recalled metal-on-metal DePuy ASR hip implants. Just yesterday, the national law firm of Parker Waichman LLP announced it had filed yet another DePuy ASR hip implant lawsuit, this time on behalf of a Virginia resident ...

Read More

Study Finds Plavix May Only Benefit Smokers

An emerging study finds that blood thinner Plavix may only benefit smokers. Plavix (clopidogrel) is prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, including the heart attacks and strokes it is supposed to prevent, gastrointestinal and cerebral bleeding, bleeding ulcers, ...

Read More

Government Penalizes 721 Hospitals for High Rates of Infections, Injuries

Medicare is reducing payments to 721 hospitals, one out of every seven hospitals in the nation, for having high rates of “hospital-acquired” conditions (HAC.

Read More

West Virginia Man Claims Metal-on-Metal DePuy Pinnacle Hip Replacement Led to Pain, Elevated Cobalt Levels

A West Virginia man fitted with a metal-on-metal version of DePuy Orthopaedics’ Pinnacle Hip Implant System has filed suit against the company and its parent, Johnson & Johnson, alleging the device caused him to suffer pain and elevated cobalt levels. The Plaintiff is being represented by the national law ...

Read More

Fracking Boom Changing Way of Life in Pennsylvania's Northern Tier

In just a few years, the impact of hydraulic fracturing (fracking) drilling on northeastern Pennsylvania is hard to miss. Thousands of natural gas wells have been opened in that area specifically in the last five years as companies look to exploit the vast Marcellus shale formation about two miles below the ...

Read More

Fracking Releasing Hazardous Chemicals into Local Waterways

Fracking Releasing Hazardous Chemicals into Local Waterways

Study shows two hazardous chemicals—ammonium & iodide—are being released & spilled into Pennsylvania and W.Virginia waterways from fracking operations in Marcellus shale.

Read More

FDA Urged to Ban Powdered Caffeine

FDA Urged to Ban Powdered Caffeine

Pennsylvania Senator Robert Casey has written to the Food and Drug Administration (FDA) to urge the agency to ban powdered caffeine, a dietary supplement.

Read More

What Action Will the FDA Take on E-cigarettes?

What Action Will the FDA Take on E-cigarettes?

As health and quality concerns trouble the e-cigarette industry, experts and the public await the Food and Drug Administration (FDA)’s action to regulate the devices.

Read More

HeartWare’s Ventricular Assist System Recall gets Highest-Risk Class I Label

HeartWare International’s recall of their Ventricular Assist System, also known as the HeartWare Ventricular Assist Device (HVAD) has been classified as Class I by the U.S. Food and Drug Administration (FDA). The Class I designation is the agency’s most serious … Continue reading

Posted in Legal News |

Johnson & Johnson Suspends Sale of Device Used in Fibroid Surgery Over Cancer Risk

Johnson & Johnson has suspended sales worldwide of the power morcellator, a device used in uterine fibroid surgery, amid concerns over its potential to spread undetected cancer beyond the uterus. The company is suspending the sale of these devices until … Continue reading

Posted in Legal News |

Doctor Says Studies of ‘Low T’ Testosterone Treatment are Urgently Needed

Many men are being treated with testosterone when there is not enough information about its risks, says a doctor in a letter to The Lancet Diabetes and Endocrinology journal. Dr. Stephanie Page, an endocrinologist at the University of Washington and … Continue reading

Posted in Legal News |

FDA Issues Safety Alert Regarding Safety of Extra Strength Acetaminophen

The U.S. Food and Drug Administration (FDA) issued a statement regarding the safety of extra strength acetaminophen in combination prescription medications. According to the agency’s safety alert, dated January 14th, health care professionals should stop prescribing and dispensing prescription drug … Continue reading

Posted in Legal News |

FDA Proposes Reclassification of Transvaginal Mesh Devices to High-Risk Category

Today, the U.S. Food and Drug Administration (FDA) issued two proposed orders for the reclassification of transvaginal mesh devices used for repair of pelvic organ prolapse (POP). If these orders are finalized, surgical mesh devices implanted to treat POP would … Continue reading

Posted in Defective Medical Devices, Health Concerns, Legal News, Transvaginal mesh |

Mylan wants Rights to Market Generic Celebrex, Sues FDA

Mylan Inc. is suing the U.S. Food and Drug Administration (FDA) over a ruling about rights to exclusively market a generic version of Celebrex (celecoxib). Pittsburgh Business Times reports that, according to Myland, the FDA would only permit exclusive 180-day … Continue reading

Posted in Legal News |

FDA to Convene Panel on Smoking Cessation Drug, Chantix, Over Psychiatric, Behavioral Side Effect Risks

The U.S. Food and Drug Administration (FDA) announced that it plans to review Chantix, the smoking cessation drug, to determine if its quit smoking benefits exceed its psychiatric and behavioral risks, Approved in 2006, Chantix received the U.S. Food and … Continue reading

Posted in Chantix, Pharmaceuticals |

FDA Warns Firms Touting Bogus Autism Cures

The U.S. Food and Drug Administration’s (FDA) national health fraud coordinator, Gary Coody, R.Ph. says that the agency has warned various firms that they face potential legal action should they continue to issue false or misleading claims concerning products and … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals, Toxic Substances |

Judge May Punish Lawyers for Misconduct in Actos Trial

Las Vegas district judge Kerry Earley is considering a request to punish lawyers for misconduct during a civil trial over the cancer risks associated with Takeda Pharmaceuticals’ diabetes drug Actos. On Thursday, Judge Earley heard arguments from an attorney representing … Continue reading

Posted in Actos, Health Concerns, Legal News, Pharmaceuticals |

Another Motion to Remand Granted in Medtronic Infuse Lawsuit

Another motion to remand has been granted in a Medtronic InFuse case, bringing the lawsuit back to the Circuit Court of the City of St. Louis. InFuse is a type of artificial bone graft that uses a genetically engineered, synthetic, … Continue reading

Posted in Legal News |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.